NIH Publishes RFAs on Myeloproliferative Disorders and Myelodysplasia
On May 21, 2004, the National Institutes of Health (NIH) published Requests for Applications (RFAs) on Myeloproliferative Disorders (MPDs) and Myelodysplasia (MDS) research. These grant opportunities are a direct result of ASH's advocacy efforts at NIH and on Capitol Hill over the past two years. Letters of intent are due January 16, 2005; applications must be completed by February 16, 2005.
The National Heart, Lung, and Blood Institute (NHLBI) and National Cancer Institute (NCI) intend to commit approximately $3.5 million in fiscal year 2005 to fund 12 new grants in response to the MPDs RFA; NHLBI is committing approximately $3 million in fiscal year 2005 to fund 10 new grants for the MDS RFA.
If you have questions or need more information about the MPDs RFA, please contact NHLBI's Jean Henslee-Downey, M.D., at (301) 435-0065 or downeyj@nhlbi.nih.gov or NCI's R. Allan Mufson, Ph.D., at (301) 496-7815 or am214t@nih.gov. If you have questions about the MDS RFA, please contact NHLBI's Dr. Henslee-Downey.
For other questions or information, please contact Jeff Coughlin, ASH Government Affairs Manager, at (202) 776-0544.
ASH compiles other research grant opportunities on its new Federal Research Grant Opportunities Web page.
|
